Sandoz Canada’s proposed entry into the medical cannabis space through its recent strategic alliance agreement with local producer Tilray broadly “complements its portfolio”, and “demonstrates again that the patient is at the heart of our work”, the Novartis affiliate has told Generics bulletin.
Sandoz Canada’s proposed entry into the medical cannabis space through its recent strategic alliance agreement with local producer Tilray broadly “complements its portfolio”, and “demonstrates again that the patient is at the heart of our work”, the Novartis affiliate has told Generics bulletin.
Last month, Tilray announced it was joining forces with Sandoz Canada to “accelerate innovation and increase availability of high-quality medical...
A look at new research on the cardiovascular effects of ADHD medications and what it means for clinical care. This article explores the latest clinical and epidemiological research on the cardiovascular effects of medications commonly prescribed for ADHD, examining potential heart-related risks, underlying mechanisms, and their implications for patient safety, clinical decision-making, and long-term treatment strategies across diverse age groups and risk profiles.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
The UK government has said it will invest almost £30m ($40.4m) in AI technologies to modernize the NHS and reduce wait times – but for the medtech sector, the devil will be in the details.
